FindTrial
Sign In

Study on the value of adjuvant radiotherapy after meningioma operation and the establishment of recurrence prediction model based on molecular and imaging omics

Study on the value of adjuvant radiotherapy after meningioma operation and the establishment of recurrence prediction model based on molecular and imaging omics

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500109806
Enrollment
Unknown
Registered
2025-09-25
Start date
2025-09-25
Completion date
Unknown
Last updated
2025-09-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Meningioma

Interventions

Meningioma cohort:None

Sponsors

The First Affiliated Hospital of Sun Yat-sen University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 100 Years

Inclusion criteria

Inclusion criteria: 1.Histologically confirmed diagnosis of meningioma. 2. Age 18 years or older. 3. Ability to complete magnetic resonance MR imaging examination.

Exclusion criteria

Exclusion criteria: 1. Patients diagnosed with other intracranial space-occupying lesions based on pathological examination. 2. Patients unable to complete the informed consent process due to cognitive or communication impairment, or those refusing to sign informed consent.

Design outcomes

Primary

MeasureTime frame
Overall suvival;Progress Free Survival;—

Countries

China

Contacts

Public ContactShen Guoping

The First Affiliated Hospital of Sun Yat-sen University

shenguop@mail.sysu.edu.cn+86 20 8775 5766

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026